Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis
Vivek Verma(Christ University), Charles B. Simone(New York Proton Center), Roy H. Decker(Yale University), Matthew M. Harkenrider(Loyola University Chicago), Christopher L. Hallemeier(Mayo Clinic in Arizona), Kyle Wang(University of North Carolina at Chapel Hill), Mutian Zhang(University of Nebraska Medical Center), Salma K. Jabbour(Rutgers, The State University of New Jersey), Valerie Shostrom(University of Nebraska Medical Center), Steve Braunstein(University of California, San Francisco), John Holland(Oregon Health & Science University), Albert Attia(Vanderbilt University), Weining Zhen(Susan Thompson Buffett Foundation), Adrian S. Iskhanian(University of Miami), Ronald C. McGarry(University of Kentucky), Percy Lee(University of California, Los Angeles)
International Journal of Radiation Oncology*Biology*Physics
December 2, 2016
Cited by 63
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Estimating Survival in Patients With Lung Cancer and Brain Metastases
|JAMA Oncology|2016|655
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
|Journal of the National Comprehensive Cancer Network|2018|632
Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
|JAMA Oncology|2022|557